Form 4 for MRNA Moderna
Accepted 2022-05-11 00:00:00 ET · period of report 2022-05-09 · accession 0001127602-22-014148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-11 | 2022-05-10 | MRNA | Meline David W | CFO | S - Sale+OE | $133.71 | -156 | 2,583 | -6% | -$20.9K |
| D | 2022-05-11 | 2022-05-09 | MRNA | Meline David W | CFO | M - OptEx | $134.40 | +348 | 2,739 | +15% | +$46.8K |
| D | 2022-05-11 | 2022-05-09 | MRNA | Meline David W | CFO | M - OptEx | $0.00 | -348 | 3,830 | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | S | D | 156 | $133.71 | 2,583 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-09 | M | A | 348 | $134.40 | 2,739 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-05-09 | M | D | 348 | $0.00 | 3,830 | D | $0.00 · — to — | 348 Common Stock | (F3) 25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |